In the June of 2016, the Board of Directors of the American Diabetes Association (ADA) asked Board Member Alan L. Yatvin to chair the ADA’s Insulin Access Workgroup to address the problem of access to affordable insulin. Charged with helping to develop and inform ADA policy, the Workgroup was made up of members and officers of the Board of Directors. Working with then-Chief Advocacy Officer, Shereen Arent, the Workgroup developed a Resolution on Insulin Affordability which was approved by the Board on November 17, 2016.
Yatvin then worked with ADA staff to build and publicize an on-line petition based on the resolution, seeking transparency in the insulin supply chain and affordable insulin. The petition also called on Congress to hold hearings to identify the reasons for the dramatic increases in insulin prices and to act to ensure all people who need insulin have affordable access to this lifesaving medication. The Stand up for Affordable Insulin Petition, has garnered over 300 thousand signatures and is the ADA’s most successful petition. Continue reading “Affordable Insulin Initiative Takes a Step Forward”